The DOI matches its Crossref record; 87 of the 90 references it cites were found in a registry or an index.
Dual Hyaluronic Acid and Folic Acid Targeting pH-Sensitive Multifunctional 2DG@DCA@MgO-Nano-Core-Shell-Radiosensitizer for Breast Cancer Therapy
Open accessPreprint — published as 10.3390/cancers13215571
Abstract
Background: Globally, breast cancer (BC) poses a serious public health risk. The disease exhibits a complex heterogeneous etiology and is associated with glycolysis and oxidative phosphorylation (OXPHOS) metabolic reprograming pathways which fuel proliferation and progression. Due to the late manifestation of symptoms, rigorous treatment regimens are required following diagnosis. Existing treatments are limited by a lack of specificity, systemic toxicity, temporary remission, and radio-resistance in BC. In this study, we developed CD44 and folate receptor-targeting multi-functional dual drug-loaded nanoparticles (DDM). These contained a hyaluronic acid (HA) and folic acid (FA) conjugated to a dichloroacetate (DCA) shell linked to a 2-deoxy glucose (2DG) and magnesium oxide (MgO) core to enhance localized chemo-radiotherapy for effective BC treatment.Methods: The physicochemical properties of nanoparticles, including stability, selectivity, release in response to pH, cellular uptake, and anticancer efficacy were comprehensively examined. Mechanistically, we identified multiple component signal pathways as important regulators of BC metabolism and mediators of inhibitory effects toward DDM.Results: Nanoparticles exhibited sustained DDM release properties in bio-relevant media, which was responsive to acidic pH providing flexibility to the control of drug release from nanoparticles. DDM-loaded and HA-FA-functionalized nanoparticles exhibited increased selectivity and uptake by BC cells. Cells study indicated that functionalized DDM significantly suppressed cancer cell growth and radiotherapy (RT) improvement via cell cycle arrest, apoptosis enhancement, and modulation of glycolysis and OXPHOS pathways.Conclusions: By highlighting DDM mechanisms as an antitumor and radio-sensitizing reagent, our analysis also revealed glycolysis and OXPHOS modulation via PI3K/AKT/mTOR/NF-κB/VEGF low and P53 high signal pathways. In conclusion, we indicated that multi-functionalized DDM depletion-mediated metabolic reprogramming via multiple signal pathways in BC cells is a promising targeted metabolic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multimodal therapeutic approaches were also described, combining radiotherapy with chemotherapy, photothermal therapy, photodynamic therapy, or immunomodulatory strategies [39,43,49,50,67,68,69].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A high degree of functionalization was reported across studies. Many nanoplatforms incorporated targeting ligands, therapeutic payloads, and microenvironment-responsive components [16,17,26,27,45,49,51,52,53].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [49]
The cited source says what the claim attributes to it.
In the citing paper
“Receptor-specific targeting, including HER2-, CXCR4-, and folate-directed systems, was frequently described and associated with increased cellular uptake [20,24,29,49,51,55,70].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [49]
The cited source says what the claim attributes to it.
In the citing paper
“Additional strategies included depletion of intracellular glutathione (GSH) and modulation of redox balance [17,19,45,47,68], as well as metabolic interventions targeting glycolysis or cellular energetics [49,69,75,76].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Antognelli, C., Palumbo, I., Aristei, C., & Talesa, V. N. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.280 · Cited by 57
RetractedWu, P., Sun, Y. L., Dong, W., Zhou, H., Guo, S., Zhang, L., Wang, X., Wan, M., & Zong, Y. (2019) · Nanoscale · doi:10.1039/c9nr01691k · Cited by 47
RetractedNano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Tumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
Raman spectroscopic study of magnetite (FeFe2O4): a new assignment for the vibrational spectrum
Shebanova, O. N., & Lazor, P. (2003) · Journal of Solid State Chemistry · doi:10.1016/s0022-4596(03)00294-9 · Cited by 905
Besufkad, A., Worku, Y., Desalegn, F., & Aragaw, D. (2011) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.4172/2157 · Cited by 847
p53 in the DNA–Damage–Repair Process
Williams, A. B., & Schumacher, B. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026070 · Cited by 835
2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents
Pajak, B., Siwiak, E., Sołtyka, M., Priebe, A., Zieliński, R., Fokt, I., Ziemniak, M., Jaśkiewicz, A., Borowski, R., Domoradzki, T., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010234 · Cited by 574
Role of metabolism in cancer cell radioresistance and radiosensitization methods
Tang, L., Wei, F., Wu, Y., He, Y., Shi, L., Xiong, F., Gong, Z., Guo, C., Li, X., Deng, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0758-7 · Cited by 409
Research works printed but not linked: 3
- Tiziana Tataranni and Claudia Piccoli. Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications. Oxidative Medicine Cellular Longevity. 2019;7:1-14. DOI.org/10.1155/2019/8201079. · DOI · Paper page
- ISO/ASTM E 51026 Practice for using the fricke dosimeter system. ASTM international, Switzerland. 2015;1:1. https://www.sis.se/std-919097.
- Yu W, et al. SIRT6 promotes the Warburg effect of papillary thyroid cancer cell BCPAP through reactive oxygen species. Onco Targets Ther. 2019;12:2861-8. https://doi.org/10.2147/OTT.S194256. · DOI
Cited by
Pan, Y., Tang, W., Fan, W., Zhang, J., & Chen, X. S. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01145f · Cited by 131
Doghish, A. S., Hashem, A. H., Shehabeldine, A. M., Sallam, A.-A. M., El-Sayyad, G. S., & Salem, S. S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103874 · Cited by 122
Self-citationNosrati, H., Ghaffarlou, M., Salehiabar, M., Mousazadeh, N., Abhari, F., Barsbay, M., Ertas, Y. N., Rashidzadeh, H., Mohammadi, A., Nasehi, L., et al. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213090 · Cited by 60
Targeted delivery of nano-radiosensitizers for tumor radiotherapy
Shi, S., Zhong, H., Zhang, Y., & Mei, Q. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216101 · Cited by 43
Zhang, C., Chen, Y., Zuo, Y., Wang, M., Chen, H., Wang, C., Cao, Y., Zeng, Y., Chen, Y., Zhang, T., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.159276 · Cited by 35
Metadata
- Authors
- Askar, M. A., Thabet, N. M., El-sayyad, G. S., El-Batal, A. I., kodous, M. A. E., Kawamura, G., Matsuda, A., Shawi, O. E. E., Helal, H., & Abdel-Rafei, M. K.
- Affiliations
- Egyptian Atomic Energy Authority (EG)
- Toyohashi University of Technology: Toyohashi Gijutsu Kagaku Daigaku
- Toyohashi University of Technology (JP)
- Egyptian Atomic Energy Authority
- Al-Azhar University (EG)
- Corresponding author
- Askar, Mostafa A.
- El-sayyad, Gharieb S.
- ORCID
- Venue
- Cancers
- Published
- 2021-09-28
- Volume
- 13
- Issue
- 21
- Pages
- 5571-5571
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC8583154
- OpenAlex
- W3214132122
- Cited by
- 27
- References
- 90
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 4 · 2023: 7 · 2022: 4
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Cancers (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Mansoura University
- Japan Society for the Promotion of Science (18H03841 and 21K18823)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Keywords
- breast cancer, hyaluronic acid, folic acid, 2-deoxyglucose, dichloroacetate, magnesium oxide nanoparticles, core-shell nanoparticles, pH-responsive drug release, CD44 targeting, folate receptor targeting, chemoradiotherapy, radiosensitization, tumor metabolic reprogramming, glycolysis, oxidative phosphorylation, PI3K/AKT/mTOR pathway, NF-κB signaling, VEGF signaling, p53 pathway, apoptosis, cell cycle arrest
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dual Hyaluronic Acid and Folic Acid Targeting pH-Sensitive Multifunctional 2DG@DCA@MgO-Nano-Core-Shell-Radiosensitizer for Breast Cancer Therapy. https://app.cochat.ai/papers/10.21203/rs.3.rs-910507/v1
- The paper
- Askar, M. A., Thabet, N. M., El-sayyad, G. S., El-Batal, A. I., kodous, M. A. E., Kawamura, G., Matsuda, A., Shawi, O. E. E., Helal, H., & Abdel-Rafei, M. K. (2021). Dual Hyaluronic Acid and Folic Acid Targeting pH-Sensitive Multifunctional 2DG@DCA@MgO-Nano-Core-Shell-Radiosensitizer for Breast Cancer Therapy. Cancers. https://doi.org/10.21203/rs.3.rs-910507/v1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.